InquirerVP Trial Day 25: Ombudsman, SEC execs to testify on SALNs, businessesDaily MaverickWHAT WE’RE WATCHING: Fractured nation, fractured family: The politics and precarity of fatherhood in turbulent timesוואלהמתקפת כטב"ם גרמה נזק למתקן תעשייתי ברוסיה한겨레자살예방 ‘109’ 전화 걸어도 절반 이상 통화 못해…지난해 응대율 47%로 ‘뚝’3DNewsВ России стартовали продажи смартфонов Oppo Reno16 с продвинутыми камерами и поддержкой ИИSözcüABD sonunda itiraf etti: İran'daki savaş cephanelikleri tükettiSCMP ChinaSingapore’s top chemist Lu Yixin confirms he will join Chinese university EIT next yearIl Fatto QuotidianoAborto farmacologico fuori dall’ospedale, l’Italia resta indietro: Regioni in ritardo tra ostacoli burocratici e delibere rimaste sulla cartaEuronewsUniversity students launch ‘student list’ to shake up Serbia’s electionsRapplerEx-vice governor to secure Maguindanao del Norte 4th District parliament seatDaily MailLisa Kudrow's son Julian, 28, towers over his mother at the 2026 Emmys as star vies for her first win in 28 yearsThe Sydney Morning HeraldAnytime Fitness’ ‘any gym’ claim found to be misleading
The Daily Newsstand · Free, Always
Tuesday, September 15, 2026

Delhi HC dismisses Vimal Elaichi maker’s plea against FDA notices to Shah Rukh Khan, Ajay Devgn, Tiger Shroff

Translate

The Delhi High Court has dismissed a plea filed by PB Agro LLP, the maker of Vimal Elaichi, challenging show-cause notices issued by the Maharashtra Food and Drug Administration (FDA) to the brand’s ambassadors Shah Rukh Khan, Ajay Devgn and Tiger Shroff over alleged misrepresentation in advertisements.

Delhi HC dismisses Vimal Elaichi Maker’s plea against FDA notices to Shah Rukh Khan, Ajay Devgn, Tiger Shroff

Justice Swarana Kanta Sharma held that the petition was not maintainable before the Delhi High Court due to lack of territorial jurisdiction. The court said that Maharashtra courts would be the more appropriate and convenient forum for the company to raise its grievances concerning the notices, in accordance with the doctrine of forum conveniens.

What is the Vimal Elaichi case?

PB Agro LLP approached the Delhi High Court after the Maharashtra FDA issued notices to actors associated with advertisements for Vimal Elaichi. The company said it engages reputed actors to promote its cardamom product under the Vimal brand and maintains that its endorsement agreements and advertising campaigns comply with applicable laws.

According to the plea, the Maharashtra FDA alleged that the Vimal Elaichi advertisements amounted to surrogate promotion of Vimal Pan Masala, a chewable product that is banned in Maharashtra. The regulator directed the actors featured in the advertisements to provide documents establishing that Vimal Elaichi is a separate product from the banned pan masala products.

The notices also sought an end to the promotional campaign and the removal of related advertising material from digital platforms.

PB Agro challenged notices issued to brand ambassadors

The company argued before the court that the August 11 notice was addressed only to the actors and not to PB Agro itself. Its counsel submitted that the company would be directly affected by any action taken by the Maharashtra regulator. The petitioner also argued that it had not been given an opportunity to present its case before the notices were issued.

The company had therefore sought relief from the Delhi High Court against the regulatory action.

However, the court rejected the plea on the ground of territorial jurisdiction.

Also Read: Mukesh Khanna calls out Shah Rukh Khan, Ajay Devgn and Tiger Shroff over Vimal Elaichi ads; demands public apology from them

Tags : , , , , , , , , , , ,

BOLLYWOOD NEWS - LIVE UPDATES

Catch us for latest Bollywood News, New Bollywood Movies update, Box office collection, New Movies Release , Bollywood News Hindi, Entertainment News, Bollywood Live News Today & Upcoming Movies 2026 and stay updated with latest hindi movies only on Bollywood Hungama.

View the original on Bollywood Hungama

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.